Coloring away chemo jitters: study tests art therapy
NCT ID NCT07435597
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested whether art therapy or mandala coloring can reduce anxiety in people receiving chemotherapy. Sixty adults were randomly assigned to either draw with their eyes closed or color a mandala design during treatment. Researchers measured anxiety levels before and after the activity to see which approach worked better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- art therapy and mandala coloring
- What this could lead to
- If successful, this could show that simple art activities like drawing or coloring help lower anxiety during chemotherapy.
- What could go wrong
- This is a small, completed study with only 60 participants. Results may not apply to all cancer patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Basaksehir Cam Sakura Hospital
Istanbul, Istanbul, 34000, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could essential oils tame chemo nausea? a new trial puts aromatherapy to the test
- Shielding the ovaries: a drug may help young breast cancer patients preserve fertility during chemo
- Can surgery for stomach or esophageal cancer cloud the mind?
- Art therapy meets oncology: could mandala coloring boost cancer Patients' well-being?
- Could a chemo boost after radiation tame aggressive prostate cancer?
- Can a targeted drug combo boost chemoradiation in EGFR-Positive lung cancer?